Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial

Supportive Care in Cancer

Volumn 24, Issue 5, 2016, Pages 2059-2066

  Heckler, Charles E ^a   Garland, Sheila N ^b   Peoples, Anita R ^a   Perlis, Michael L ^c   Shayne, Michelle ^a   Morrow, Gary R ^a   Kamen, Charles ^a   Hoefler, Jenine ^a   Roscoe, Joseph A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Armodafinil; Cancer; Cancer related fatigue; CBT I

Indexed keywords

ARMODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE; WAKEFULNESS PROMOTING AGENT;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BRIEF FATIGUE INVENTORY; CANCER CHEMOTHERAPY; CANCER SURVIVOR; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; EFFECT SIZE; FACIT FATIGUE SCALE; FACTORIAL DESIGN; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; STRUCTURAL EQUATION MODELING; UNSPECIFIED SIDE EFFECT; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOPHYSIOLOGY; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; SURVIVOR; TREATMENT OUTCOME;

BENZHYDRYL COMPOUNDS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; SURVIVORS; TREATMENT OUTCOME; WAKEFULNESS-PROMOTING AGENTS;

EID: 84946430903     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2996-y     Document Type: Article

References (44)

1. Bower JE (2014) Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597–609. doi:10.1038/nrclinonc.2014.127
2. Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P, Ancoli-Israel S, Reeve BB, Mustian K, O’Mara A, Lai JS, Fisch M, Cella D, National Cancer Institute Clinical Trials Planning M (2013) Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst 105(19):1432–1440. doi:10.1093/jnci/djt242
3. Menning S, de Ruiter MB, Veltman DJ, Koppelmans V, Kirschbaum C, Boogerd W, Reneman L, Schagen SB (2015) Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment—the role of fatigue. Neuroimage Clin 7:547–554. doi:10.1016/j.nicl.2015.02.005
4. Sekse RJ, Hufthammer KO, Vika ME (2015) Fatigue and quality of life in women treated for various types of gynaecological cancers: a cross-sectional study. J Clin Nurs 24(3–4):546–555. doi:10.1111/jocn.12647
5. Gerber LH, Stout N, McGarvey C, Soballe P, Shieh CY, Diao G, Springer BA, Pfalzer LA (2011) Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer 19(10):1581–1591. doi:10.1007/s00520-010-0986-7
6. Scott JA, Lasch KE, Barsevick AM, Piault-Louis E (2011) Patients’ experiences with cancer-related fatigue: a review and synthesis of qualitative research. Oncol Nurs Forum 38(3):E191–203. doi:10.1188/11.ONF.E191-E203
7. Paiva CE, Paiva BS (2013) Prevalence, predictors, and prognostic impact of fatigue among Brazilian outpatients with advanced cancers. Support Care Cancer 21(4):1053–1060. doi:10.1007/s00520-012-1625-2
8. Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, McCready DR, Wong RK, Jiang H, Howell D (2015) Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. doi:10.1007/s11764-015-0450-2
9. Minton O, Stone PC (2012) A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care 2(3):231–238. doi:10.1136/bmjspcare-2011-000172
10. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G (2013) Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. J Pain Symptom Manag 45(2):213–222. doi:10.1016/j.jpainsymman.2012.02.009
11. Pertl MM, Hevey D, Collier S, Lambe K, O’Dwyer AM (2014) Predictors of fatigue in cancer patients before and after chemotherapy. J Health Psychol 19(6):699–710. doi:10.1177/1359105313477675
12. Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O’Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI (2010) Cancer-related fatigue. J Natl Compr Cancer Netw 8(8):904–931
13. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M, Consortium G (2010) I’m so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19(10):1419–1427. doi:10.1007/s11136-010-9757-7
14. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26(6):971–982. doi:10.1200/JCO.2007.10.7805
15. Savard J, Simard S, Ivers H, Morin CM (2005) Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 23(25):6083–6096. doi:10.1200/JCO.2005.09.548
16. Matthews EE, Berger AM, Schmiege SJ, Cook PF, McCarthy MS, Moore CM, Aloia MS (2014) Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. Oncol Nurs Forum 41(3):241–253. doi:10.1188/14.ONF.41-03AP
17. Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS (2014) Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol Off J Am Soc Clin Oncol 32(5):449–457. doi:10.1200/JCO.2012.47.7265
18. Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J (2008) Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 26(28):4651–4658. doi:10.1200/JCO.2007.13.9006
19. Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T (2014) Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat 10:1113–1124. doi:10.2147/NDT.S47790
20. Fleming L, Randell K, Harvey CJ, Espie CA (2014) Does cognitive behaviour therapy for insomnia reduce clinical levels of fatigue, anxiety and depression in cancer patients? Psycho-Oncology 23(6):679–684. doi:10.1002/pon.3468
21. Zee PC, Ancoli-Israel S, Workshop P (2009) Does effective management of sleep disorders reduce cancer-related fatigue? Drugs 69(Suppl 2):29–41. doi:10.2165/11531140-000000000-00000
22. Dirksen SR, Epstein DR (2008) Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 61(6):664–675. doi:10.1111/j.1365-2648.2007.04560.x
23. Savard J, Simard S, Ivers H, Morin CM (2005) Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Oncol 23(25):6097–6106. doi:10.1200/JCO.2005.12.513
24. Hovey E, de Souza P, Marx G, Parente P, Rapke T, Hill A, Bonaventura A, Michele A, Craft P, Abdi E, Lloyd A, Investigators M (2014) Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Support Care Cancer 22(5):1233–1242. doi:10.1007/s00520-013-2076-0
25. Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, O’Brien M, Stone P, Benepal T, Bates N, Wee B (2014) Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 32(18):1882–1888. doi:10.1200/JCO.2013.54.4346
26. Boele FW, Douw L, de Groot M, van Thuijl HF, Cleijne W, Heimans JJ, Taphoorn MJ, Reijneveld JC, Klein M (2013) The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro-Oncology 15(10):1420–1428. doi:10.1093/neuonc/not102
27. Berenson JR, Yellin O, Shamasunder HK, Chen CS, Charu V, Woliver TB, Sanani S, Schlutz M, Nassir Y, Swift RA, Andreu-Vieyra C, Vescio R (2014) A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma. Support Care Cancer. doi:10.1007/s00520-014-2486-7
28. Roscoe JA, Garland SN, Heckler CE, Perlis ML, Peoples AR, Shayne M, Savard J, Daniels NP, Morrow GR (2014) Randomized placebo-controlled trial of cognitive behavioral therapy and armodafinil for insomnia after cancer treatment. J Clin Oncol. doi:10.1200/JCO.2014.57.6769
29. Perlis ML, Jungquist C, Smith MT, Posner D (2005) Cognitive behavioral tretament of insomnia: a session-by-session guide. Springer, New York
30. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186–1196
31. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582–592. doi:10.1097/01.MLR.0000062554.74615.4C
32. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag 24(6):547–561
33. Savard MH, Savard J, Simard S, Ivers H (2005) Empirical validation of the insomnia severity index in cancer patients. Psychooncology 14(6):429–441. doi:10.1002/pon.860
34. Little RJA, Rubin DB (2002) Statistical analysis with missing data. Wiley, Hoboken
35. van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:219–242
36. van Buuren S, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45(3):1548–7660
37. Enders CK (2010) Applied missing data analysis. Guilford, New York
38. van Buuren S (2012) Flexible imputation of missing data, Chapman and Hall/CRC interdisciplinary statistics series. CRC, Boca Raton, FL
39. Byrne BM (2012) Structural equation modeling with Mplus: basic concepts, applications, and programming, Multivariate applications series. Routledge Academic, New York
40. Brown JN, Howard CA, Kemp DW (2010) Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 44(6):1098–1103. doi:10.1345/aph.1M705
41. Golicki D, Bala MM, Niewada M, Wierzbicka A (2010) Modafinil for narcolepsy: systematic review and meta-analysis. Med Sci Monit 16(8):RA177–186
42. Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP (2009) Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. J Clin Psychiatry 70(1):104–112
43. Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, Peppone L, Hemstad A, Esparaz BT, Hopkins JO (2010) A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 116(14):3513–3520. doi:10.1002/cncr.25083
44. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G (2009) Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev 1:CD006953. doi:10.1002/14651858.CD006953.pub2